Oligonucleotide-mediated gene modification and its promise for animal agriculture.
One of the great aspirations in modern biology is the ability to utilise the expanding knowledge of the genetic basis of phenotypic diversity through the purposeful tailoring of the mammalian genome. A number of technologies are emerging which have the capacity to modify genes in their chromosomal context. Not surprisingly, the major thrust in this area has come from the evaluation of gene therapy applications to correct mutations implicated in human genetic diseases. The recent development of somatic cell nuclear transfer (SCNT) provides access to these technologies for the purposeful modification of livestock animals. The enormous phenotypic variety existent in contemporary livestock animals has in many cases been linked to quantitative trait loci (QTL) and their underlying point mutations, often referred to as single-nucleotide polymorphisms (SNPs). Thus, the ability for the targeted genetic modification of livestock animals constitutes an attractive opportunity for future agricultural applications. In this review, we will summarize attempts and approaches for oligonucleotide-mediated gene modification (OGM) strategies for the site-specific modification of the genome, with an emphasis on chimeric RNA-DNA oligonucleotides (RDOs) and single-stranded oligonucletides (ssODNs). The potential of this approach for the directed genetic improvement of livestock animals is illustrated through examples, outlining the effects of point mutations on important traits, including meat and milk production, reproductive performance, disease resistance and superior models of human diseases. Current technological hurdles and potential strategies that might remove these barriers in the future are discussed.
Laible
Götz
G
AgResearch, Ruakura Research Centre, PB 3123, Hamilton, New Zealand. goetz.laible@agresearch.co.nz
Wagner
Stefan
S
Alderson
Jon
J
D000820:Animal Diseases / Q000235:genetics; D000818:Animals; D000829:Animals, Domestic / Q000235:genetics*; D002875:Chromosomes / Q000235:genetics*; D019976:Cloning, Organism / Q000379:methods; D030342:Genetic Diseases, Inborn / Q000235:genetics; D015316:Genetic Therapy / Q000379:methods; D016678:Genome / Q000235:genetics*; D006801:Humans; D008460:Meat; D008892:Milk; D016297:Mutagenesis, Site-Directed / Q000379:methods; D053652:Nuclear Transfer Techniques; D009838:Oligodeoxyribonucleotides / Q000235:genetics*; D009843:Oligoribonucleotides / Q000235:genetics*; D010641:Phenotype; D017354:Point Mutation; D040641:Quantitative Trait Loci / Q000235:genetics
D009838:Oligodeoxyribonucleotides; D009843:Oligoribonucleotides